Suppr超能文献

组胺引起的犬脑静脉体外舒张是由组胺H2受体介导的。

In vitro relaxation of dog cerebral veins in response to histamine is mediated by histamine H2 receptors.

作者信息

Monge L, García-Villalón A L, Fernández N, García J L, Gómez B, Diéguez G

机构信息

Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid, Spain.

出版信息

Eur J Pharmacol. 1997 Nov 5;338(2):135-41. doi: 10.1016/s0014-2999(97)81941-3.

Abstract

There is little information on the histamine receptor mechanisms involved in cerebral venodilation, thus the role of histamine present in human cerebrospinal fluid is difficult to assess. In isolated canine pial veins, concentration-response curves to histamine (10[-7]-10[-3] M), the histamine H1 receptor agonist, 2-pyridylethylamine (10[-6]-10[-2] M), the histamine H2 receptor agonist, dimaprit (S-(3-dimethylaminopropyl) isothiourea dihydrochloride, 10[-6]-10[-2] M), and the histamine H3 receptor agonist, imetit (S-[2-(1 midazol-4-yl)ethyl]isothiourea dihydrobromide, 10[-7]-10[-3] M) were isometrically determined. In resting veins, histamine, 2-pyridylethylamine and dimaprit had no significant effect, whereas in endothelin-1-precontracted veins, these drugs produced concentration-dependent relaxation (Emax in % of active tone and pD2 were: for histamine, 72 +/- 6 and 5.36 +/- 0.09; for 2-pyridylethylamine, 59 +/- 5 and 3.28 +/- 0.05; for dimaprit, 65 +/- 7 and 4.81 +/- 0.10, respectively). The relaxations in response to histamine and dimaprit were competitively antagonized by the histamine H2 receptor antagonist, cimetidine (3 x 10[-6]-10[-4] M) (pA2 = 6.07 +/- 0.03 for histamine, and 6.09 +/- 0.07 for dimaprit), but were not affected by the histamine H1 receptor antagonist, chlorpheniramine (10[-6] M) or the histamine H3 receptor antagonist, thioperamide (N-cyclohexyl-4-(1-H-imidazol-4-yl)-1-piperidine-carbothioamide maleate, 10[-6] M). The relaxation in response to 2-pyridylethylamine was inhibited by cimetidine (10[-5] M), but not by chlorpheniramine (10[-6] M). Imetit produced a small contraction in resting veins (14 +/- 4 mg) and precontracted veins (20 +/- 3 mg), which was not modified by thioperamide (10[-6] M). The relaxation of veins in response to histamine was not modified by endothelium removal, nor by the inhibitor of nitric oxide synthase, N(G)-nitro-L-arginine methyl ester (10[-4] M), or the cyclooxygenase inhibitor, meclofenamate (10[-5] M). Therefore, in pial veins: (1) histamine produces relaxation by activation of histamine H2 receptors, probably located in the smooth musculature, with no participation of histamine H1 and H3 receptors, and (2) endothelium, nitric oxide and prostanoids are probably not involved in the relaxation in response to histamine.

摘要

关于参与脑静脉扩张的组胺受体机制的信息很少,因此人脑脊液中组胺的作用难以评估。在分离的犬软脑膜静脉中,以等长方式测定了对组胺(10[-7]-10[-3]M)、组胺H1受体激动剂2-吡啶乙胺(10[-6]-10[-2]M)、组胺H2受体激动剂二甲双胍(S-(3-二甲氨基丙基)异硫脲二盐酸盐,10[-6]-10[-2]M)和组胺H3受体激动剂碘美替丁(S-[2-(1-咪唑-4-基)乙基]异硫脲二氢溴酸盐,10[-7]-10[-3]M)的浓度-反应曲线。在静息静脉中,组胺、2-吡啶乙胺和二甲双胍无显著作用,而在内皮素-1预收缩的静脉中,这些药物产生浓度依赖性舒张(最大舒张率以主动张力的百分比表示,pD2分别为:组胺,72±6和5.36±0.09;2-吡啶乙胺,59±5和3.28±0.05;二甲双胍,65±7和4.81±0.10)。组胺和二甲双胍引起的舒张被组胺H2受体拮抗剂西咪替丁(3×10[-6]-10[-4]M)竞争性拮抗(组胺的pA2 = 6.07±0.03,二甲双胍的pA2 = 6.09±0.07),但不受组胺H1受体拮抗剂氯苯那敏(10[-6]M)或组胺H3受体拮抗剂硫代哌酰胺(N-环己基-4-(1-H-咪唑-4-基)-1-哌啶-碳硫酰胺马来酸盐,10[-6]M)影响。2-吡啶乙胺引起的舒张被西咪替丁(10[-5]M)抑制,但不受氯苯那敏(10[-6]M)影响。碘美替丁在静息静脉(14±4mg)和预收缩静脉(20±3mg)中产生小的收缩,硫代哌酰胺(10[-6]M)对此无影响。组胺引起的静脉舒张不受内皮去除、一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(10[-4]M)或环氧化酶抑制剂甲氯芬那酸(10[-5]M)的影响。因此,在软脑膜静脉中:(1)组胺通过激活可能位于平滑肌组织中的组胺H2受体产生舒张,组胺H1和H3受体不参与,(2)内皮、一氧化氮和前列腺素可能不参与组胺引起的舒张。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验